22nd century group (nasdaq: xxii) acquires gvb biopharma, a leading hemp/cannabis company

Buffalo, n.y., may 13, 2022 (globe newswire) -- 22nd century group, inc. (nasdaq: xxii), a leading agricultural biotechnology company dedicated to improving human health with reduced nicotine tobacco, hemp/cannabis, and hops advanced plant technology, today announced the acquisition of privately held gvb biopharma. as a contract development and manufacturing organization (cdmo), gvb is believed to be one of the largest providers of hemp-derived active ingredients for the pharmaceutical and consumer goods industries worldwide based on total tonnage.
XXII Ratings Summary
XXII Quant Ranking